No lawyers and no budget can be key to successful PPPs, says Novartis
This article was originally published in Scrip
Novartis believes that it has found a solution to making certain types of public private partnerships work where others have failed: Removing legal contracts and budgets from the equation can help private sector companies work together to make these partnerships succeed, explained Novartis' Jim Barrington, director of SMS for Life, a programme designed to reduce shortages of antimalarials and the fruit of such a partnership.
You may also be interested in...
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to be made available to those who need them. But industry says that relaxing IP protections is not the solution and that many companies have already invested significant amounts of money in potential new treatments and vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
Intellectual property rights are under the microscope as countries prepare to provide affordable and timely access to pandemic technologies.